IRIS
Pizzato, Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.347
AS - Asia 1.594
EU - Europa 1.150
SA - Sud America 318
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 7.460
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.299
SG - Singapore 674
CN - Cina 311
VN - Vietnam 306
IT - Italia 292
BR - Brasile 258
RU - Federazione Russa 185
UA - Ucraina 99
FI - Finlandia 97
DE - Germania 87
FR - Francia 84
GB - Regno Unito 72
LV - Lettonia 61
SE - Svezia 53
IN - India 52
HK - Hong Kong 47
KR - Corea 41
NL - Olanda 31
ID - Indonesia 29
CA - Canada 26
AR - Argentina 24
TR - Turchia 24
BD - Bangladesh 21
AT - Austria 18
IQ - Iraq 17
PL - Polonia 17
JP - Giappone 15
EC - Ecuador 13
MX - Messico 12
ZA - Sudafrica 12
ES - Italia 8
JO - Giordania 8
VE - Venezuela 8
CL - Cile 7
TN - Tunisia 7
BG - Bulgaria 6
CZ - Repubblica Ceca 6
PK - Pakistan 6
UZ - Uzbekistan 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
EG - Egitto 4
HU - Ungheria 4
KE - Kenya 4
LB - Libano 4
LT - Lituania 4
TW - Taiwan 4
AL - Albania 3
BY - Bielorussia 3
CH - Svizzera 3
CO - Colombia 3
CR - Costa Rica 3
GR - Grecia 3
IE - Irlanda 3
IL - Israele 3
JM - Giamaica 3
MA - Marocco 3
PY - Paraguay 3
TH - Thailandia 3
AU - Australia 2
AZ - Azerbaigian 2
ET - Etiopia 2
EU - Europa 2
HR - Croazia 2
IR - Iran 2
KZ - Kazakistan 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
PH - Filippine 2
PS - Palestinian Territory 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GM - Gambi 1
HN - Honduras 1
KG - Kirghizistan 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
RS - Serbia 1
RW - Ruanda 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
UY - Uruguay 1
YT - Mayotte 1
Totale 7.460
Salva come PNG Salva come JPEG
Città #
Fairfield 508
Ashburn 482
Singapore 436
Chandler 281
Woodbridge 249
Seattle 228
Jacksonville 221
Wilmington 192
San Jose 178
Cambridge 176
Houston 165
Santa Clara 132
Dallas 131
Ann Arbor 108
Columbus 103
Moscow 87
Trento 85
Princeton 84
Ho Chi Minh City 83
San Mateo 81
Los Angeles 73
Hanoi 66
Beijing 63
New York 62
Riga 61
The Dalles 55
Lauterbourg 54
Council Bluffs 53
Helsinki 47
Munich 38
Seoul 36
Hong Kong 34
Boardman 31
Orem 30
Chicago 26
Como 26
San Diego 25
São Paulo 24
London 23
Rome 22
Da Nang 21
Jakarta 21
Dearborn 20
Buffalo 18
Chennai 18
Hefei 16
Milan 15
Redondo Beach 15
Warsaw 15
Tokyo 14
Montreal 13
Dong Ket 12
Frankfurt am Main 12
Brooklyn 11
Haiphong 11
Johannesburg 11
Vienna 11
Lappeenranta 9
San Paolo di Civitate 9
St Louis 9
Verona 9
Amsterdam 8
Falkenstein 8
Guangzhou 8
Poplar 8
Hillsboro 7
Izmir 7
Mumbai 7
Nuremberg 7
Turku 7
Atlanta 6
Denver 6
Elk Grove Village 6
Jinan 6
Mexico City 6
Rio de Janeiro 6
Sofia 6
Stockholm 6
Tashkent 6
Turin 6
Washington 6
Belo Horizonte 5
Biên Hòa 5
Brasília 5
Bremen 5
Dhaka 5
Düsseldorf 5
Fort Worth 5
Fremont 5
New Delhi 5
Phoenix 5
Quito 5
Salt Lake City 5
Shanghai 5
Toronto 5
Baghdad 4
Brno 4
Brugherio 4
Can Tho 4
Istanbul 4
Totale 5.372
Salva come PNG Salva come JPEG
Nome #
A bipartite structural organization defines the SERINC family of HIV-1 restriction factors 211
A Community Study of SARS-CoV-2 Detection by RT-PCR in Saliva: A Reliable and Effective Method 209
HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation 208
SERINC5 as a new restriction factor for human immunodeficiency virus and murine leukemia virus 207
SARS-CoV-2 and the Host Cell: A Tale of Interactions 198
SERINC5 protein inhibits HIV-1 fusion pore formation by promoting functional inactivation of envelope glycoproteins 194
Galanin pathogenic mutations in temporal lobe epilepsy 194
Retroviral factors promoting infectivity. 174
Mechanical activation of Efavirenz: the effects on the dissolution and inhibitory behavior 171
The antiviral activity of rodent and lagomorph SERINC3 and SERINC5 is counteracted by known viral antagonists 170
Serology study after BTN162b2 vaccination in participants previously infected with SARS-CoV-2 in two different waves versus naïve 169
Centriolar distal appendages activate the centrosome-PIDDosome-p53 signalling axis via ANKRD26 166
The Potency of Nef-Mediated SERINC5 Antagonism Correlates with the Prevalence of Primate Lentiviruses in the Wild 162
The antagonism of HIV Nef to SERINC5 particle infectivity restriction involves the counteraction of virion-associated pools of the restriction factor 162
Evidence for nonspecific adsorption of targeted retrovirus vector particles to cells. 161
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 159
The host-cell restriction factor SERINC5 restricts HIV-1 infectivity without altering the lipid composition and organization of viral particles 158
S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3 155
Gene Therapy of Glioblastoma Multiforme with a Bicistronic Retroviral Vector Expressing Human IL-2 and HSV-tK. 153
Effect of High-Energy Milling on the Dissolution of Anti-HIV Drug Efavirenz in Different Solvents 152
Lv4 Is a Capsid-Specific Antiviral Activity in Human Blood Cells That Restricts Viruses of the SIVMAC/SIVSM/HIV-2 Lineage Prior to Integration 151
Gene therapy of glioblastoma multiforme via combined expression of suicide and cytokine genes: a pilot study in humans. 148
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity 141
Development of a suspension packaging cell line for production of high titre, serum-resistant murine leukemia virus vectors. 135
Dynamin 2 is required for the enhancement of HIV-1 infectivity by Nef. 132
TRIM5 is an innate immune sensor for the retrovirus capsid lattice. 132
Effect of differential growth conditions on the dTTP pool size in herpes simplex virus-infected Vero cells. 130
Cyclosporine blocks incorporation of HIV-1 envelope glycoprotein into virions. 128
A one-step SYBR Green I-based product-enhanced reverse transcriptase assay for the quantitation of retroviruses in cell culture supernatants. 128
Progress with retroviral gene vectors. 124
Insertion of targeting domains into the envelope glycoprotein of Moloney murine leukemia virus (MoMLV)-based vectors modulates the route of mCAT-1-mediated viral entry. 123
SARS-CoV-2 vaccination elicits unconventional IgM specific responses in naïve and previously COVID-19-infected individuals 121
Nef can enhance the infectivity of receptor-pseudotyped human immunodeficiency virus type 1 particles. 120
Viral particles imaging through evanescent wave scattering in a total internal reflection laser microscope 114
Quantification of reverse transcriptase activity by real-time PCR as a fast and accurate method for titration of HIV, lenti- and retroviral vectors. 112
Heparin binds to murine leukemia virus and inhibits Env-independent attachment and infection. 112
Molecular cloning, complete sequence, and biological characterization of a xenotropic murine leukemia virus constitutively released from the human B-lymphoblastoid cell line DG-75. 111
Determination of HPRT mutant frequency and molecular analysis of T-lymphocyte mutants derived from coke-oven workers. 111
Identification of gammaretroviruses constitutively released from cell lines used for human immunodeficiency virus research. 110
Nef decreases HIV-1 sensitivity to neutralizing antibodies that target the membrane-proximal external region of TMgp41. 105
Nef enhances human immunodeficiency virus type 1 infectivity in the absence of matrix. 105
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α. 105
Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer. 104
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 101
Localization to detergent-resistant membranes and HIV-1 core entry inhibition correlate with HIV-1 restriction by SERINC5 101
MLV glycosylated-Gag is an infectivity factor that rescues Nef-deficient HIV-1. 100
A Conserved Acidic Residue in the C-Terminal Flexible Loop of HIV-1 Nef Contributes to the Activity of SERINC5 and CD4 Downregulation 97
Herpes simplex virus chronically infected human T lymphocytes are susceptible to HIV-1 superinfection and support HIV-1 pseudotyping. 97
The activity of Nef on HIV-1 infectivity. 90
Doxycycline Inhibition of a Pseudotyped Virus Transduction Does Not Translate to Inhibition of SARS-CoV-2 Infectivity 90
Host Restriction Factors Modulating HIV Latency and Replication in Macrophages 82
Initial binding of murine leukemia virus particles to cells does not require specific Env-receptor interaction. 79
Trends and symptoms of SARS-CoV-2 infection: a longitudinal study on an Alpine population representative sample 76
Retrovirus vectors. 75
The impact of infection risk communication format on tourism travel intentions during COVID-19 68
Impaired ability of Nef to counteract SERINC5 is associated with reduced plasma viremia in HIV-infected individuals 67
Prospective epidemiological, molecular, and genetic characterization of a novel coronavirus disease in the Val Venosta/Vinschgau: the CHRIS COVID-19 study protocol 64
Influence of Different Glycoproteins and of the Virion Core on SERINC5 Antiviral Activity 55
A Two-Step Ion-Exchange Process for Modified Mechanical Reinforcement and Virucidal Functionalization of Glasses 38
Totale 7.615
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 487
Totale 30.911
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021226 0 0 0 0 0 0 0 0 0 74 99 53
2021/2022481 22 32 8 20 12 31 7 106 48 49 59 87
2022/2023607 63 68 6 69 52 87 9 54 113 35 31 20
2023/2024332 20 20 18 20 34 84 21 22 5 13 12 63
2024/20251.332 17 11 75 247 79 166 115 82 137 234 76 93
2025/20262.651 184 82 330 476 362 186 519 81 214 217 0 0
Totale 7.615